EyeOnFDA reports (see “Hold It!“):
“Senator Charles Grassley (R-Iowa) has gone and put a hold on the nomination of Dr. Andrew C. von Eschenbach. There was movement to try to get him approved in the lame-duck Senate session, but the hold would put that into doubt.”
“According to reports, this hold is rooted in concerns about the approval of Ketek, manufactured by Sanofi Aventis…other holds placed on this nomination were solely for political objectives – one regarding importation, one regarding abortion by Senators Vitter (R-Louisiana) and DeMint (R-S. Carolina), respectively.”
For more on the Ketek issue, see “Celsius 3014: Ketek, Drug Safety, & Bioterrorism.”
It appears that the von Eschenbach nomination is headed for turkeyville; I know I am.